Belluscura (FRA:9VQ) Current Deferred Taxes Liabilities : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Belluscura's current deferred tax liabilities for the quarter that ended in Jun. 2023 was €0.00 Mil.

Belluscura Current Deferred Taxes Liabilities Historical Data

The historical data trend for Belluscura's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Current Deferred Taxes Liabilities Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Current Deferred Taxes Liabilities

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial				-	-	-	-	-

Belluscura Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Belluscura's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines